{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:44:22Z","timestamp":1783035862133,"version":"3.54.6"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.rmed.2019.03.012","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T11:50:06Z","timestamp":1553341806000},"page":"14-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosis"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-7985","authenticated-orcid":false,"given":"Marc A.","family":"Judson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Jou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakash","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrawattie","family":"Sukhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furqan","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavril","family":"Rosoklija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Recai","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmed.2019.03.012_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12016-014-8450-y","article-title":"The clinical features of sarcoidosis: a comprehensive review","volume":"49","author":"Judson","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"11","key":"10.1016\/j.rmed.2019.03.012_bib2","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2019.03.012_bib3","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1378\/chest.115.4.1158","article-title":"An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment","volume":"115","author":"Judson","year":"1999","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2019.03.012_bib4","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1183\/09031936.00060612","article-title":"Established and experimental medical therapy of pulmonary sarcoidosis","volume":"41","author":"Baughman","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2019.03.012_bib5","first-page":"219","article-title":"Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases","volume":"61","author":"Mana","year":"1994","journal-title":"Respir. Int. Rev. Thorac. Dis."},{"issue":"2","key":"10.1016\/j.rmed.2019.03.012_bib6","first-page":"123","article-title":"Respiratory symptoms at presentation and long-term vital prognosis in patients with pulmonary sarcoidosis","volume":"11","author":"Vestbo","year":"1994","journal-title":"Sarcoidosis"},{"issue":"2","key":"10.1016\/j.rmed.2019.03.012_bib7","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American thoracic society\/European respiratory society\/world association of sarcoidosis and other granulomatous disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"3","key":"10.1016\/j.rmed.2019.03.012_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccm.2008.03.009","article-title":"The diagnosis of sarcoidosis","volume":"29","author":"Judson","year":"2008","journal-title":"Clin. Chest Med."},{"issue":"1","key":"10.1016\/j.rmed.2019.03.012_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5261","key":"10.1016\/j.rmed.2019.03.012_bib10","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation","volume":"2","author":"Scadding","year":"1961","journal-title":"Br. Med. J."},{"issue":"1","key":"10.1016\/j.rmed.2019.03.012_bib11","first-page":"75","article-title":"Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS research group. A case Control etiologic study of sarcoidosis","volume":"16","author":"Judson","year":"1999","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"1","key":"10.1016\/j.rmed.2019.03.012_bib12","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"4","key":"10.1016\/j.rmed.2019.03.012_bib13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccm.2015.08.014","article-title":"Quality of life assessment in sarcoidosis","volume":"36","author":"Judson","year":"2015","journal-title":"Clin. Chest Med."},{"issue":"7","key":"10.1016\/j.rmed.2019.03.012_bib14","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1164\/rccm.201410-1785OC","article-title":"Validation and important differences for the sarcoidosis assessment tool. A new patient-reported outcome measure","volume":"191","author":"Judson","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2019.03.012_bib15","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG task force","volume":"28","author":"Baughman","year":"2011","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"2","key":"10.1016\/j.rmed.2019.03.012_bib16","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"1","key":"10.1016\/j.rmed.2019.03.012_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.rmed.2013.11.019","article-title":"The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial","volume":"108","author":"Judson","year":"2014","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2019.03.012_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rmed.2015.11.007","article-title":"A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients","volume":"110","author":"Baughman","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2019.03.012_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2019.03.012_bib20","first-page":"27","article-title":"Presentation of sarcoidosis and outcome of pulmonary changes","volume":"29","author":"Romer","year":"1982","journal-title":"Dan. Med. Bull."},{"issue":"2","key":"10.1016\/j.rmed.2019.03.012_bib21","first-page":"158","article-title":"The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases","volume":"17","author":"Pietinalho","year":"2000","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.rmed.2019.03.012_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.12703\/P6-89","article-title":"Advances in the diagnosis and treatment of sarcoidosis","volume":"6","author":"Judson","year":"2014","journal-title":"F1000prime reports"},{"issue":"2","key":"10.1016\/j.rmed.2019.03.012_bib23","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch. Pathol. Lab Med."},{"issue":"3","key":"10.1016\/j.rmed.2019.03.012_bib24","first-page":"275","article-title":"Causes of death in patients with chronic sarcoidosis","volume":"33","author":"Hu","year":"2016","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"4","key":"10.1016\/j.rmed.2019.03.012_bib25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.rmed.2019.03.012_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1378\/chest.128.1.30","article-title":"Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands","volume":"128","author":"Smedema","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2019.03.012_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijcard.2016.10.101","article-title":"Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis","volume":"227","author":"Padala","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.rmed.2019.03.012_bib28","first-page":"280","article-title":"The indications for the treatment of sarcoidosis : Well's law","volume":"34","author":"Baughman","year":"2017","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"4","key":"10.1016\/j.rmed.2019.03.012_bib29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-0037-1602589","article-title":"Quality of life in sarcoidosis","volume":"38","author":"Judson","year":"2017","journal-title":"Semin. Respir. Crit. Care Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119300873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119300873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:47:43Z","timestamp":1760615263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611119300873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":29,"alternative-id":["S0954611119300873"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2019.03.012","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2019.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}